Pluristem Therapeutics Stock Price (NASDAQ:PSTI)

Add to My Stocks
$1.26 $0.02 (1.61%) PSTI stock closing price Jun 22, 2018 (Closing)
Prev Close* : $1.24
Market Cap:
$137.48M
Day Low: $1.21
52 Week Low: $1.06
Open: $1.24
Volume: -
Day High: $1.26
52 Week High: $2.12
Dividend:
0.00

Latest Stock Market News

Latest Articles

Pluristem Therapeutics News - From Partners

PSTI Stockcharts

View PSTI PE ratio, PS ratio stocks charts and compare with peers.
PSTI Chart
Note: Compare Pluristem Therapeutics stock price history with the index and industry peers.

Pluristem Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Pluristem Therapeutics Returns

ROE
(return on equity)
-75%

Pluristem Therapeutics Financial Ratios

Asset Turnover
0
Receivables Turnover
0.12
Debt to Equity
0
Dividend Yield
-999.0000

PSTI Industry Peers

Company Price Change (%)
Xbiotech (XBIT)4.250.08 (1.85%)
Dimension Therapeutics (DMTX)5.950 (0%)
Mesoblast (MESO)5.860.2 (3.3%)
Capricor Therapeutics (CAPR)1.410.03 (2.17%)
Actelion (ALIOF)278.50 (0%)
Vericel Corp (VCEL)110.05 (0.46%)
Cesca Therapeutics (KOOL)0.440.03 (6.38%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Nymox Pharmaceutical (NYMX)3.890.64 (19.69%)
Vital Therapies (VTL)6.50.7 (12.07%)
AVID BIOSERVICS (CDMO)3.530.26 (7.95%)
MiMedx (MDXG)5.980.39 (6.98%)
BioDelivery Sciences (BDSI)3.10.2 (6.9%)
Arbutus Biopharma (ABUS)6.80.43 (6.75%)
Sorrento Therapeutics (SRNE)6.550.4 (6.5%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018
CompanyPriceChange (%)
Bluebird Bio (BLUE)168.918.45 (9.85%)
Uniquire (QURE)36.183.32 (8.41%)
GTx (GTXI)17.31.19 (6.44%)
Sarepta Therapeutics (SRPT)140.339.32 (6.23%)
Amicus Therapeutics (FOLD)15.810.7 (4.24%)
Amarin (AMRN)2.880.12 (4%)
Compugen (CGEN)3.650.15 (3.95%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018

Pluristem Therapeutics Inc. Stock News - Partner Headlines

GuruFocus insider data   on Sep 27, 2015

Pluristem Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-2.84M---
Net Income-27.81M-23.24M-24.67M-26.93M-21.15M
Total Operating Expense28.01M26.06M25.63M28.21M22.87M
View Pluristem Therapeutics income statement
balance sheet20172016201520142013
Total Assets37.53M45.94M68.15M74.02M68.31M
Total Liabilities7.28M7.78M10.01M11.9M10.85M
Shareholders Equity30.25M38.15M58.14M62.12M57.46M
View Pluristem Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.13M-0.92M-2.63M-0.59M-
Net Cash from (used by) Operating Activities-21.61M-18.52M-20.6M-19.12M-16.88M
Increase (Decrease) in Prop Plant And Equipment-0.34M-1.72M-0.81M-1.57M-4.3M
View Pluristem Therapeutics cash flow statement

Pluristem Therapeutics Stock Message Board

Pluristem Therapeutics stock price ended the last trading day at $1.26. Stock price or share price can be used to find the total market value of a company. Pluristem Therapeutics market cap stands at $137.48M as of Jun 22, 2018. Pluristem Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy PSTI stock than sell it, then Pluristem Therapeutics stock price goes up. Conversely, if more investors wanted to sell PSTI stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 125,636 on the last trading day, as is evident from Pluristem Therapeutics stock chart, and PSTI stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Pluristem Therapeutics stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Pluristem Therapeutics stock price history.